New York City Metropolitan Area
Patrick Weinberg is an energetic, high-impact CFO, Board Member, and Senior Private Equity Advisor with a 35+ year track record of driving enterprise value, cash generation, and operational accountability across global public and PE-backed organizations. As the Principal of Vinea Executive Advisory LLC, he currently provides strategic board oversight, audit chair leadership, and specialized CFO advisory services to top-tier private equity sponsors. Patrick’s expertise spans the entire investment lifecycle—from rigorous pre-acquisition selection, carve-outs/onboardings and complex post-deal integration to executing the full CFO playbook resulting in Cashflow optimization, EBITDA (margin) growth and high-multiplier exits. A true cross-cultural leader - with both EU and US roots - he has steered international operations across 15+ countries and built high-performance teams on four continents. He is fluent in English and Dutch, and conversant in German. Recent Leadership & Portfolio Impact: - Marquee Exits: Recently served as CFO for ILC Dover, a New Mountain Capital portfolio company. Partnered with the executive team to lead the highly successful $2.3 billion cash sale to Ingersoll Rand (NYSE: IR). - Private Equity Advisory & Carve-Outs: Currently driving the complex financial workstreams and a strategic carve-out for Montagu and Kohlberg & Company. Concurrently serving as a Senior Advisor for Montagu, providing CFO advisory services across their healthcare portfolio. - Board Governance: Board Member and Audit Chair at Ascential Technologies, an AEA Investors portfolio company. - Global Philanthropy: Deeply committed to international impact, serving on the Board of Directors for pediatric cancer charities ACT for Children (Switzerland) and World Child Cancer (USA), driving diagnostics, medical access, and survival-rate initiatives in developing nations.
Montagu is a leading mid-market private equity firm, committed to finding and growing businesses that make the world work. Focussing on businesses with a must-have product or service in a structurally growing marketplace, Montagu brings proven growth capabilities to help companies achieve their ambitions and unlock their full potential. Montagu specialises in carve-out and other first time buyout investments and has deep expertise in five priority sectors: Healthcare, Financial Sector Services, Critical Data, Digital Infrastructure and Education. ESG forms an integral part of its strategy, and its commitment to responsible investment is fully integrated into its investment and value-creation process. Montagu partners with companies with enterprise values between €200 million and €1 billion and has €14bn assets under management. For additional information on Montagu, visit www.montagu.com
Ascential Technologies designs, develops, and automates complex diagnostics, inspection and test processes across medical & life sciences, transportation, and aerospace & specialty industrial end markets. Ascential Technologies is a portfolio company of AEA Investors, an investment firm with an extensive history of partnering with leading companies in the industrial technology and automation industries.
Vinea Executive Advisory provides tactical Board Director, Audit Chair, and specialized CFO Advisory services designed explicitly to help PE sponsors bridge the "experience gap" in the portfolio finance function and maximize enterprise value. Backed by over 35 years of finance and audit experience - including 12 years as a PE portfolio CFO with a track record of driving 4x+ money multiples – Vinea Executive Advisory steps in as a collaborative partner to: - Carve-Out & Onboard: Ensuring Day 1 Readiness and accelerating the "First 100 Days" by establishing hyper-transparent reporting cadences, structuring robust compliance and internal controls, and upgrading the finance talent bench. - Amplify CFO Playbook: Driving transformation and margin expansion through data visualization and specific CFO playbook initiatives such as salesforce and pricing excellence, working capital optimization, and M&A advisory for tuck-in acquisitions. - Drive CFO Excellence: Bridging the "experience gap" by supporting and coaching especially newly appointed or less-experienced PE CFOs, ensuring the stamina, focus, and technical precision required to operate in high-pressure, accelerated hold periods. - Market & Exit: Maximizing exit value by crafting growth narratives, preparing virtual data rooms, and expertly structuring and defending the Seller’s Quality of Earnings (QofE) - specifically substantiating Reported, Management, and Pro Forma Adjustments to EBITDA. - Provide Board & Audit Leadership: Serving as an engaged independent Board Director or Audit Chair, leveraging deep experience in international corporate governance, unqualified audit opinions, and comprehensive cybersecurity risk management. Vinea Executive Advisory offers a highly flexible, collaborative engagement model that aligns senior management with Sponsor objectives, eliminating costly operational oversights, accelerating transformation, and significantly enhancing transaction multiples upon exit.
World Child Cancer's vision is to see a world where every child with cancer has access to the best possible treatment and care. Our mission is to improve cancer diagnosis, treatment and palliative care for children across the developing world, redressing the global inequality in the treatment of child cancer. World Child Cancer does this by facilitating and funding international twinning partnerships linking hospitals in developed and developing countries to create a two-way transfer of medical expertise and skills to save lives and reduce suffering.
As CFO of ILC Dover, a portfolio company of New Mountain Capital, Mr. Weinberg was a key member of the team that transformed the company and led the successful sale in 2024 to publicly traded Ingersoll Rand for $2.3 billion in cash. ILC Dover - now Ingersoll Rand Life Sciences - is a global leader in the innovative design and manufacturing of high-performance flexible materials and protective solutions for the aerospace, medical device and (bio)pharmaceutical industries.